Nano-Oncology: Clinical Application for Cancer Therapy and Future Perspectives

Table 8

Examples of targeted liposome in clinical trials.

Compound	Therapeutic agent	Status	Targeting agent
MCC-465	Doxorubicin	Phase I	F(ab’)2 fragment of human antibody GAH
MBP-426	Oxaliplatin	Phase II	Transferrin
SGT-53	Plasmid DNA with p53 gene	Phase I	Transferrin receptor antibody fragment
CALAA-01	Small interfering RNA	Phase I	Transferrin